Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

GL Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$60M
Portfolio companies 10
Lead investments 3
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Life Science

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Apjohn ventures Kalamazoo, Michigan, United States
Clearbanc Canada, Ontario, Toronto
Clipperton France, Ile-de-France, Paris
Consonance Capital Partners New York, New York, United States
Danbei Qiye China, Ningbo, Zhejiang
East West Capital Limited Australia, New South Wales, Sydney
Harmony Fund -
IU Angel Network Bloomington, Indiana, United States
NIPR Kansas City, Missouri, United States
OMERS Ventures Canada, Ontario, Toronto
Resolute Venture Partners Brentwood, Tennessee, United States
Resolute Ventures California, San Francisco, United States
Starboard Value New York, New York, United States
Telligent Capital Management China, Hong Kong, Hong Kong Island
USAMRMC -
Workforce Partners Connecticut, United States, Wilton
Yield10 Bioscience Massachusetts, United States, Woburn
Zoom Venture Lancaster, Pennsylvania, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Asia Pacific Medical Group

Health Care
Hospital
Medical
16 Nov 2022 Minhang, Shanghai, China

Nest

Health Care
Medical
Medical Device
07 Jun 2022 Wuxi, Anhui, China

Duoning Biotech

Biotechnology
Health Care
24 Nov 2021 Shanghai, China

Hzymes Biotechnology

$123M10 Nov 2021 Wuhan, Hubei, China

Tongshu Gene

Genetics
Life Science
Medical
Medical Device
$77M15 Jun 2021 Changzhou, Zhejiang, China

Biotechnology
Life Science
Pharmaceutical
$188M14 Jan 2021 North Holland

Huayin Health

Health Care
Medical
$85M08 Apr 2020 Yuexiu District, Guangdong Province, China

Pharmaron

Biotechnology
Chemical
Pharmaceutical
$40M24 Feb 2011 Waltham, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GL Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 60M
Peak activity year 2021
Lead investments 3
Exits 2
Group Appearance index 0.90

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Asia Pacific Medical Group

Health Care
Hospital
Medical
16 Nov 2022 Minhang, Shanghai, China

Nest

Health Care
Medical
Medical Device
07 Jun 2022 Wuxi, Anhui, China

Duoning Biotech

Biotechnology
Health Care
24 Nov 2021 Shanghai, China

Hzymes Biotechnology

$123M10 Nov 2021 Wuhan, Hubei, China

Tongshu Gene

Genetics
Life Science
Medical
Medical Device
$77M15 Jun 2021 Changzhou, Zhejiang, China

Biotechnology
Life Science
Pharmaceutical
$188M14 Jan 2021 North Holland

Huayin Health

Health Care
Medical
$85M08 Apr 2020 Yuexiu District, Guangdong Province, China

Pharmaron

Biotechnology
Chemical
Pharmaceutical
$40M24 Feb 2011 Waltham, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: